Harbour Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08K Hold
204
﹤0.01% 3877
2026
Q1
$3.91K Hold
204
﹤0.01% 3683
2025
Q4
$4.48K Hold
204
﹤0.01% 3054
2025
Q3
$2.48K Hold
204
﹤0.01% 3219
2025
Q2
$3.8K Hold
204
﹤0.01% 2971
2025
Q1
$3.91K Hold
204
﹤0.01% 2907
2024
Q4
$7.35K Hold
204
﹤0.01% 2591
2024
Q3
$8.65K Hold
204
﹤0.01% 2419
2024
Q2
$8.22K Buy
204
+4
+2% +$167 ﹤0.01% 2340
2024
Q1
$7.08K Hold
200
﹤0.01% 2346
2023
Q4
$5.92K Sell
200
-66
-25% -$1.37K ﹤0.01% 2353
2023
Q3
$5.53K Hold
266
﹤0.01% 2235
2023
Q2
$6.53K Hold
266
﹤0.01% 2194
2023
Q1
$10.8K Sell
266
-6
-2% -$248 ﹤0.01% 1979
2022
Q4
$12.2K Sell
272
-44
-14% -$1.99K ﹤0.01% 1870
2022
Q3
$19K Hold
316
﹤0.01% 1687
2022
Q2
$19K Buy
+316
New +$25.9K ﹤0.01% 1687
2021
Q4
$48K Sell
316
-452
-59% -$61K ﹤0.01% 1288
2021
Q3
$92K Sell
768
-485
-39% -$53.4K ﹤0.01% 1425
2021
Q2
$122K Hold
1,253
﹤0.01% 1296
2021
Q1
$111K Buy
+1,253
New +$116K ﹤0.01% 1251

Other funds holding TNDM

Harbour Investments's TNDM Position: Q2 2026 in Review

Harbour Investments held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 204 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3877.

Harbour Investments first reported a position in TNDM in Q1 2021 and has held it in 21 quarters since. The position peaked at $122K in Q2 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Harbour Investments held 204 shares of Tandem Diabetes Care worth $3.08K as of Q2 2026.
  • Harbour Investments left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3877 holding.
  • Harbour Investments first reported a position in Tandem Diabetes Care in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Tandem Diabetes Care position peaked at $122K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.